Developments in Screening Tests and Strategies for Colorectal Cancer

Table 1

Screening recommendations (adapted from Short et al. [110]).

Organization	Screen and interval	Age
United States Preventive Services Task Force (USPSTF)	() Fecal occult blood (1-year); () Flexible sigmoidoscopy (5-year) + high-sensitivity FOBT (3-year); () Colonoscopy (10-year)	50+ years
American College of Gastroenterology	Preferred; () Colonoscopy (10-year); () FIT (1-year), if colonoscopy declined; Alternative (prevention); () Flexible sigmoidoscopy (5- to 10-year); () CT colonography (5-year); Alternative (cancer detection); () gFOBT (1-year); () Stool DNA (3-year)	45+ years for blacks; 50+ years everyone else
American Cancer Society	Adenoma and cancer; () Flexible sigmoidoscopy (5-year); () Colonoscopy (10-year); () Double-contrast barium enema (5-year); () CT colonography (5-year); Cancer; () High-sensitivity FOBT (1-year); () FIT (1-year); () Stool DNA (Cologuard) (uncertain)	50+ years